Literature DB >> 2183161

Expression of p60fyn in human platelets.

I D Horak1, M L Corcoran, P A Thompson, L M Wahl, J B Bolen.   

Abstract

Platelets possess high levels of tyrosine protein kinase activity which has been associated, in part, with the abundant expression of pp60c-src. We report here that in addition to pp60c-src at least one other member of the src family of tyrosine protein kinases, p60fyn, is expressed in platelets. The abundance of p60fyn was estimated to be approximately 20- to 40-fold higher in platelets than in human fibroblasts. In platelets the abundance of p60fyn was determined to be approximately 5- to 10-fold lower than the abundance of pp60c-src. Thrombin-mediated activation of human platelets was found to rapidly elevate the level of detectable phosphotyrosine containing proteins. However, thrombin treatment of platelets did not result in significant alterations in either the abundance or activity of pp60c-src or p60fyn. These observations demonstrate that at least two members of the src family of tyrosine protein kinases (pp60c-src and p60fyn) are expressed in human platelets, but leave unresolved the question of whether these protein kinases play a role in platelet signal transduction events.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2183161

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  19 in total

Review 1.  The c-src family of protein-tyrosine kinases.

Authors:  P M Brickell
Journal:  Int J Exp Pathol       Date:  1991-02       Impact factor: 1.925

2.  Translocation of the Csk homologous kinase (Chk/Hyl) controls activity of CD36-anchored Lyn tyrosine kinase in thrombin-stimulated platelets.

Authors:  A Hirao; I Hamaguchi; T Suda; N Yamaguchi
Journal:  EMBO J       Date:  1997-05-01       Impact factor: 11.598

3.  Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets.

Authors:  A S Weyrich; D A Dixon; R Pabla; M R Elstad; T M McIntyre; S M Prescott; G A Zimmerman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

Review 4.  Targeting Fyn Kinase in Alzheimer's Disease.

Authors:  Haakon B Nygaard
Journal:  Biol Psychiatry       Date:  2017-06-13       Impact factor: 13.382

5.  p42 mitogen-activated protein kinase and p90 ribosomal S6 kinase are selectively phosphorylated and activated during thrombin-induced platelet activation and aggregation.

Authors:  J Papkoff; R H Chen; J Blenis; J Forsman
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

6.  Thrombin and thrombin receptor agonist peptide induce tyrosine phosphorylation and tyrosine kinases in the platelet cytoskeleton. Translocation of pp60c-src and integrin alpha IIb beta 3 (glycoprotein IIb/IIIa) is not required for aggregation, but is dependent on formation of large aggregate structures.

Authors:  K M Pumiglia; M B Feinstein
Journal:  Biochem J       Date:  1993-08-15       Impact factor: 3.857

7.  Redistribution of activated pp60c-src to integrin-dependent cytoskeletal complexes in thrombin-stimulated platelets.

Authors:  E A Clark; J S Brugge
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

8.  Substrate affinity of the protein tyrosine kinase pp60c-src is increased on thrombin stimulation of human platelets.

Authors:  U Liebenhoff; D Brockmeier; P Presek
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

9.  Evidence for a role for tyrosine phosphorylation of phospholipase C gamma 2 in collagen-induced platelet cytosolic calcium mobilization.

Authors:  J L Daniel; C Dangelmaier; J B Smith
Journal:  Biochem J       Date:  1994-09-01       Impact factor: 3.857

10.  Activation of signal transduction in platelets by the tyrosine phosphatase inhibitor pervanadate (vanadyl hydroperoxide).

Authors:  K M Pumiglia; L F Lau; C K Huang; S Burroughs; M B Feinstein
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.